ReviewFrontiers in microbiology2025
DDX3X and virus interactions: functional diversity and antiviral strategies.
Review in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Dissecting the Interaction Domains of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicase DDX3X and Search for Potential Inhibitors.International journal of molecular sciences · 2026Article
- Structural and functional perspectives on DEAD-box RNA helicases in the rubber tree cold stress response.Frontiers in plant science · 2026Review
- Ddx3xa mutations drive cardiac defects in a zebrafish model via dysregulation of wnt/β-catenin signaling.Frontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a core member of the DEAD-box helicase family, DDX3X modulates RNA metabolic networks through its ATPase activity, RNA helicase function, and nucleic acid-binding capacity to participate in bidirectional regulation of innate immune responses and virus-host interactions. Multiple viruses achieve effective genome replication and immune evasion by hijacking DDX3X's enzymatic activities or interfering with its mediated immune signaling transduction. Nevertheless, hosts have evolved strategies to exploit DDX3X for activating interferon signaling pathways and other antiviral mechanisms, establishing multilayered defense networks. This review systematically elaborates the functional diversity exhibited by DDX3X protein in virus interaction networks. DDX3X orchestrates viral genomic RNA processing during replication. Simultaneously, it interacts with host restriction factors to evade antiviral immunity, establishing a dynamic balance between viral propagation and host defense. The functional plasticity of DDX3X not only elucidates immune regulatory mechanisms in host-pathogen coevolution, but also provides novel molecular perspectives for deciphering zoonotic transmission barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.